TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 0 | -3 | 2 | -9 | -14 | 0 | -6 |
| P | %wins | 100 | 0 | 100 | 0 | 0 | 40 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/8/17 16:15 | 6/6/17 | TTOO | T2 Biosystems, Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Deptula-Hicks Darlene M | MA | O | SVP,CFO | P | 14 | 3.58 | 0 | 4 | New | 4 | D | ||||||||||||||
6/15/16 17:00 | 6/13/16 | PIRS | Pieris Pharmaceuticals, Inc. | NV | Health | Biolab | Commercial Physical & Biologi | Deptula-Hicks Darlene M | MA | O | SVP,CFO | P | 8 | 1.66 | 0 | 5 | New | 5 | D | -48 | -33 | -2 | -12 | -8 | -14 | -6 | 0 | -3 | 2 | -9 | -14 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |